Probity Advisors, Inc. Zoetis Inc. Transaction History

Probity Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Probity Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 2,314 shares of ZTS stock, worth $409,485. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,314

Previous 2,331 0.73%

Holding current value

$409,485

Previous $404,000 11.88%

% of portfolio

0.09%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$172.58 - $196.48 $2,933 - $3,340	-17 Reduced 0.73%	2,314 $452,000
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $60,835 - $74,750	418 Added 21.85%	2,331 $404,000
Q1 2024 May 02, 2024	BUY	$165.67 - $199.94 $17,561 - $21,193	106 Added 5.87%	1,913 $323,000
Q4 2023 Feb 12, 2024	SELL	$151.44 - $200.09 $1,211 - $1,600	-8 Reduced 0.44%	1,807 $356,000
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $4,178 - $4,819	25 Added 1.4%	1,815 $315,000
Q2 2023 Aug 10, 2023	SELL	$160.94 - $186.23 $17,864 - $20,671	-111 Reduced 5.84%	1,790 $308,000
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $10,622 - $12,755	-81 Reduced 4.09%	1,901 $278,000
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $9,935 - $12,230	67 Added 3.5%	1,982 $294,000
Q2 2022 Aug 12, 2022	BUY	$155.97 - $200.09 $779 - $1,000	5 Added 0.26%	1,915 $329,000
Q1 2022 May 10, 2022	SELL	$181.39 - $234.03 $20,134 - $25,977	-111 Reduced 5.49%	1,910 $360,000
Q4 2021 Feb 10, 2022	SELL	$193.69 - $247.03 $31,765 - $40,512	-164 Reduced 7.51%	2,021 $493,000
Q3 2021 Oct 08, 2021	SELL	$189.29 - $209.69 $30,286 - $33,550	-160 Reduced 6.82%	2,185 $424,000
Q2 2021 Aug 06, 2021	SELL	$155.9 - $187.99 $33,362 - $40,229	-214 Reduced 8.36%	2,345 $437,000
Q1 2021 Apr 28, 2021	SELL	$144.0 - $169.39 $52,128 - $61,319	-362 Reduced 12.39%	2,559 $403,000
Q3 2020 Nov 09, 2020	SELL	$137.1 - $165.37 $6,443 - $7,772	-47 Reduced 1.58%	2,921 $483,000
Q2 2020 Aug 03, 2020	SELL	$111.92 - $142.53 $28,875 - $36,772	-258 Reduced 8.0%	2,968 $407,000
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $42,438 - $66,382	-458 Reduced 12.43%	3,226 $380,000
Q4 2019 Feb 13, 2020	SELL	$116.25 - $133.25 $80,910 - $92,742	-696 Reduced 15.89%	3,684 $488,000
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $16,322 - $18,622	-145 Reduced 3.2%	4,380 $546,000
Q2 2019 Aug 08, 2019	SELL	$97.98 - $114.28 $21,261 - $24,798	-217 Reduced 4.58%	4,525 $514,000
Q1 2019 Apr 29, 2019	BUY	$81.56 - $100.67 $32,868 - $40,570	403 Added 9.29%	4,742 $477,000
Q4 2018 Feb 12, 2019	SELL	$79.28 - $95.27 $26,638 - $32,010	-336 Reduced 7.19%	4,339 $371,000
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $2,755 - $3,076	33 Added 0.71%	4,675 $428,000
Q2 2018 Aug 13, 2018	SELL	$79.9 - $89.2 $18,776 - $20,962	-235 Reduced 4.82%	4,642 $395,000
Q1 2018 Apr 16, 2018	SELL	$71.51 - $84.69 $20,094 - $23,797	-281 Reduced 5.45%	4,877 $407,000
Q4 2017 Feb 09, 2018	SELL	$63.24 - $72.8 $335,361 - $386,058	-5,303 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$59.73 - $65.4 $316,748 - $346,816	5,303	5,303 $338,000

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account

Probity Advisors, Inc. Zoetis Inc. Transaction History